Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - NET CHANGE IN CASH
Net Change in Cash URGN - UroGen Pharma Ltd.
39.6 M
LAST VALUE
158.01%
2 YEAR CAGR
-9.26%
5 YEAR CAGR
47.33%
10 YEAR CAGR